Search Results - "MECO, D"

Identification of novel SEC61G-EGFR fusions in pediatric ependymoma by Servidei, T, Meco, D, Muto, V, Tartaglia, M, Riccardi, R

“…An abstract of a study by Servidei et al assessing identification of novel SEC61G-EGFR fusions in pediatric ependymoma is presented. Compared to EPR EPP-MI…”
Get full text

The combination of yondelis and cisplatin is synergistic against human tumor xenografts by D'Incalci, M., Colombo, T., Ubezio, P., Nicoletti, I., Giavazzi, R., Erba, E., Ferrarese, L., Meco, D., Riccardi, R., Sessa, C., Cavallini, E., Jimeno, J., Faircloth, G.T.

“…Yondelis™ (trabectidin, ET-743) is a marine natural product that has shown activity both in preclinical systems and in human malignancies such as soft tissue…”
Get full text

Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models by Meco, D., Servidei, T., Lamorte, G., Binda, E., Arena, V., Riccardi, R.

Get full text

The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin by Servidei, T., Ferlini, C., Riccardi, A., Meco, D., Scambia, G., Segni, G., Manzotti, C., Riccardi, R.

“…BBR3464 is a new platinum-based drug non cross-resistant with cisplatin. To characterise the cellular basis of BBR3464 cytotoxicity as opposed to cisplatin, we…”
Get full text

214 Human ependymoma tumor-initiating cells (TICs) as a model for preclinical studies on EGFR-kinase inhibitors (EGFR-KIs) by Meco, D, Servidei, T, Trivieri, N, Zannoni, G.F, Pallini, R, Maira, G, Riccardi, R

Get full text

State of the Art on Modelling Inductive Power Transfer for EVs by Meco, D. De, Dolara, A., Longo, M., Yaici, W.

“…The increasing diffusion of Electric Vehicles (EVs) is driving academic and institutional research towards exploring different possible ways of charging…”
Get full text

Antitumour activity of oxaliplatin in neuroblastoma cell lines by Riccardi, A, Ferlini, C, Meco, D, Mastrangelo, R, Scambia, G, Riccardi, R

“…Oxaliplatin appears non cross-resistant with cisplatin and has a comparable antitumour effect both in preclinical and clinical studies. We compared the…”
Get full text

139 - Identification of novel SEC61G-EGFR fusions in pediatric ependymoma by Servidei, T., Meco, D., Muto, V., Tartaglia, M., Riccardi, R.

Get full text

Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor by Screpanti, I, Morrone, S, Meco, D, Santoni, A, Gulino, A, Paolini, R, Crisanti, A, Mathieson, BJ, Frati, L

“…We have studied the effects of the steroid hormones, 17 beta-estradiol and dexamethasone, on the relative proportion of thymocyte expression of CD4 (L3T4), CD8…”
Get full text

Influence of cisplatin and doxorubicin on 125 I-meta-iodobenzylguanidine uptake in human neuroblastoma cell lines by Meco, D, Lasorella, A, Riccardi, A, Servidei, T, Mastrangelo, R, Riccardi, R

Get full text

Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor by de Grazia, U, Felli, M P, Vacca, A, Farina, A R, Maroder, M, Cappabianca, L, Meco, D, Farina, M, Screpanti, I, Frati, L, Gulino, A

“…The differentiating agent retinoic acid (RA) has been previously reported to interfere with 12-O-tetradecanoyl-phorbol-13-acetate (TPA)/Ca2+-induced signals…”
Get full text

Neuromodulatory Loop Mediated by Nerve Growth Factor and Interleukin 6 in Thymic Stromal Cell Cultures by Screpanti, Isabella, Meco, Daniela, Scarpa, Susanna, Morrone, Stefania, Frati, Luigi, Gulino, Alberto, Modesti, Andrea

“…Neural crest cell derivatives have been suggested to be involved in thymus development. We established nonlymphoid thymic stromal cell cultures capable of…”
Get full text

Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif by FELLI, M. P, VACCA, A, MECO, D, SCREPANTI, I, FARINA, A. R, MARODER, M, MARTINOTTI, S, PETRANGELI, E, FRATI, L, GULINO, A

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Enhancement of natural-killer-cell susceptibility of human breast-cancer cells by estradiol and v-Ha-ras oncogene by Screpanti, I, Felli, M P, Toniato, E, Meco, D, Martinotti, S, Frati, L, Santoni, A, Gulino, A

“…Natural killer (NK) cells are putative components of the cellular immune response to transformed cells. Since both estradiol treatment and ras-oncogene…”
Get more information

Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat by DONALD, Sarah, VERSCHOYLE, Richard D, RICCARDI, Riccardo, LOPEZ-LAZARO, Luis, JIMENO, Jose, GESCHER, Andreas J, GREAVES, Peter, GANT, Timothy W, COLOMBO, Tina, ZAFFARONI, Marco, FRAPOLLI, Roberta, ZUCCHETTI, Massimo, D'INCALCI, Maurizio, MECO, Daniela

“…Yondelis (ET-743) is a promising antitumor drug with hepatotoxic properties in animals and humans. Here the hypothesis was tested that dexamethasone can…”
Get full text

Antitumor activity of imatinib mesylate in neuroblastoma xenografts by Meco, Daniela, Riccardi, Anna, Servidei, Tiziana, Brueggen, Josef, Gessi, Marco, Riccardi, Riccardo, Dominici, Carlo

“…Imatinib mesylate has antitumor activity in vitro and in vivo against neuroblastoma cell lines and xenografts characterized by a different expression of…”
Get full text

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies by MECO, Daniela, COLOMBO, Tina, UBEZIO, Paolo, ZUCCHETTI, Massimo, ZAFFARONI, Marco, RICCARDI, Anna, FAIRCLOTH, Glynn, JOSE, Jimeno, D'INCALCI, Maurizio, RICCARDI, Riccardo

“…To investigate the cytotoxic and antitumor effects of the combination of the novel anticancer drug ET-743 and doxorubicin (Dx) and to determine whether any…”
Get full text

The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: A comparative study with SN38 and topotecan by Di Francesco, Angela Maria, Riccardi, Anna Shirley, Barone, Giuseppe, Rutella, Sergio, Meco, Daniela, Frapolli, Roberta, Zucchetti, Massimo, D’Incalci, Maurizio, Pisano, Claudio, Carminati, Paolo, Riccardi, Riccardo

“…Neuroblastoma is one of the most common extracranial solid tumours in childhood with a poor prognosis in its advanced stage. Treatment failure is often…”
Get full text

A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study) by Finocchiaro, Gaetano, Gentner, Bernhard, Farina, Francesca, Capotondo, Alessia, Eoli, Marica, Anghileri, Elena, Carabba, Matteo Giovanni, Cuccarini, Valeria, DI Meco, Francesco, Legnani, Federico, Pollo, Bianca, Bruzzone, Maria Grazia, Saini, Marco, Ferroli, Paolo, Pallini, Roberto, Olivi, Alessandro, Mazzoleni, Stefania, Russo, Carlo, Naldini, Luigi, Ciceri, Fabio

“…Abstract only 2532 Background: Genetically modified cell-based therapies are relevant in immuno-oncology due to their potential for tumor specificity &…”
Get full text

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft by Riccardi, Anna, Meco, Daniela, Ubezio, Paolo, Mazzarella, Giorgio, Marabese, Mirko, Faircloth, Glynn T, Jimeno, José, DʼIncalci, Maurizio, Riccardi, Riccardo

“…Our objective was to evaluate in vitro and in vivo the effect of the combination of trabectedin (Yondelis, ET-743) and irinotecan (CPT-11) or its major…”
Get full text